Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Neuropharmacology

  • You have access
    In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2AReceptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045)
    Shigeru Okuyama, Shigeyuki Chaki, Ryoko Yoshikawa, Yoshiko Suzuki, Shin-Ichi Ogawa, Yasuko Imagawa, Naoya Kawashima, Yoko Ikeda, Toshihito Kumagai, Atsuro Nakazato, Masashi Nagamine and Kazuyuki Tomisawa
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 56-63;
  • You have access
    S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: I. Interaction with Cloned Human (h)5-HT1A, Dopamine hD2/hD3 and hα2A-Adrenergic Receptors in Relation to Modulation of Cortical Monoamine Release and Activity in Models of Potential Antidepressant Activity
    Mark J. Millan, Adrian Newman-Tancredi, Jean-Michel Rivet, Mauricette Brocco, Pierre Lacroix, Valérie Audinot, Laetitia Cistarelli and Alain Gobert
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 132-147;
  • You have access
    Effect of Smoking History on [3H]Nicotine Binding in Human Postmortem Brain
    Charles R. Breese, Michael J. Marks, Judy Logel, Cathy E. Adams, Bernadette Sullivan, Allan C. Collins and Sherry Leonard
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 7-13;
  • You have access
    S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
    Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 148-161;
  • You have access
    Transport of Clonidine Across Cultured Brain Microvessel Endothelial Cells
    Jörg Huwyler, Gert Fricker, Michael Török, Markus Schneider and Jürgen Drewe
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 81-85;
  • You have access
    [35S]Guanosine-5′-O-(3-thio)triphosphate Binding as a Measure of Efficacy at Human Recombinant Dopamine D4.4Receptors: Actions of Antiparkinsonian and Antipsychotic Agents
    A. Newman-Tancredi, V. Audinot, C. Chaput and L.Verrièle and M. J. Millan
    Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 181-191;
  • You have access
    Partial Agonism by 3α,21-Dihydroxy-5β-pregnan-20-one at the γ-Aminobutyric AcidA Receptor Neurosteroid Site
    Bao G. Xue, Edward R. Whittemore, Chong H. Park, Richard M. Woodward, Nancy C. Lan and Kelvin W. Gee
    Journal of Pharmacology and Experimental Therapeutics June 1997, 281 (3) 1095-1101;
  • You have access
    Differential Muscarinic Receptor Binding of Acetylcholinesterase Inhibitors in Rat Brain, Human Brain and Chinese Hamster Ovary Cells Expressing Human Receptors
    Ingeborg van den Beukel, Fred A. Dijcks, Patrick Vanderheyden, Georges Vauquelin and Marga Oortgiesen
    Journal of Pharmacology and Experimental Therapeutics June 1997, 281 (3) 1113-1119;
  • You have access
    Anticonvulsant Action of 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in Immature Rats: Comparison with the Effects on Motor Performance
    P. Mares, A. Mikulecká and M. Pometlová
    Journal of Pharmacology and Experimental Therapeutics June 1997, 281 (3) 1120-1126;
  • You have access
    The Stereo-Isomers of the Anticonvulsant ARL 12495AA Limit Sustained Repetitive Firing and Modify Action Potential Properties of Rat Hippocampal Neurons in Vitro
    S. K. Norris and A. E. King
    Journal of Pharmacology and Experimental Therapeutics June 1997, 281 (3) 1191-1198;

Pages

  • Previous
  • Next
  • 1
  • …
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • …
  • 221
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics